Perfil
Dr. Bianca Brundel is Chief Scientific Officer at NYKEN BV.
He received his graduate degree from the University of Amsterdam and a doctorate degree from the University of Groningen.
Antiguos cargos conocidos de Bianca Brundel.
| Empresas | Cargo | Fin |
|---|---|---|
Nyken BV
 Nyken BV Pharmaceuticals: GenericHealth Technology Nyken BV develops heat-shock-protein drugs for treatment of chronic diseases. Its products include NYK-1001, a drug that is used for the treatment of gastric discomfort and gastric bleeding in China, Japan, and internationally, NYK-1005, a chemical derivative that is used for atrial myocyte screening and drug identifying discovery system and NYK-1007, an early drug candidate used in heat shock proteins. The company was founded by Herman Steen in 2009 and is headquartered in Groningen, the Netherlands. | Director Técnico/Científico/I+D | - |
Formación de Bianca Brundel.
| University of Amsterdam | Graduate Degree |
| University of Groningen | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Nyken BV
Nyken BV Pharmaceuticals: GenericHealth Technology Nyken BV develops heat-shock-protein drugs for treatment of chronic diseases. Its products include NYK-1001, a drug that is used for the treatment of gastric discomfort and gastric bleeding in China, Japan, and internationally, NYK-1005, a chemical derivative that is used for atrial myocyte screening and drug identifying discovery system and NYK-1007, an early drug candidate used in heat shock proteins. The company was founded by Herman Steen in 2009 and is headquartered in Groningen, the Netherlands. | Health Technology |
- Bolsa de valores
- Insiders
- Bianca Brundel
